Daily Financial Update
Market Pulse: Crypto markets ripped higher as Bitcoin reclaimed $85K amid a classic short squeeze, dragging digital assets back into the spotlight.
Key Movers: Micron crushed estimates with an AI-driven revenue outlook, while Accenture posted blowout results and record bookings, sending both names to fresh highs.
Macro & Politics: The EMA accelerated PolyPid’s D-PLEX₁₀₀ review as Merck quietly pulled Recarbrio from U.S. shelves and Cronus Pharma launched Florfinasone™ Otic for dogs.
What’s Next: Futures are holding key support but watch Treasury yields and any Fed remarks for potential volatility spikes.
Market Commentary
What everyone’s missing is that while Bitcoin ripped through the $85K wall (see “Bitcoin leads crypto market rebound above $85K as short liquidations accelerate,” The Times of India), there’s a leftover pile of long-dated positions that haven’t been tested—one more catalyst could blow that open. I’m seeing margin calls quietly stacking, and that’s where chaos really brews.
Look at the AI earnings bonanza at Micron and Accenture and pair that with the regulatory shuffle in pharma—on one side you have chip supercycle optimism, on the other government moves at the EMA and FDA level. It’s as if cheap money is getting taxed by red tape at the same time, putting pressure on tech momentum when the next Fed meeting rolls around.
Don’t just ride the earnings wave—trim some risk and set stops under critical support in names like MU and ACN, and keep an eye on drug approval timelines for a regulatory hit. If the Fed speaks hawkish, rotate back into short-term Treasuries ahead of any big M&A news.
📈 Breaking Financial News
Bitcoin leads crypto market rebound above $85K as short liquidations accelerate
Crypto markets rose on Friday as total market capitalisation reached $3.042 trillion, with Bitcoin reclaiming $85,000 amid easing Treasury yields and a short squeeze. Bitcoin gained about 2%, while Ethereum held above $2,700. Investors now await US jobs data …
Futures Rise, S&P 500 Finds Key Support; Micron Crushes Views
Dow Jones futures rose early Thursday, along with S&P 500 futures and Nasdaq futures. Micron Technology earnings beat late Wednesday while Google released a new cutting-edge AI model. The stock market rally was mixed Wednesday as Treasury yields hit new long-…
Accenture rallies more than 20% after earnings beat, heads for best day ever
Shares of Accenture surged Thursday after the company's fiscal fourth-quarter results beat estimates.
Accenture Stock Soars 22% as Earnings Beat, Record Bookings and Upbeat 2027 Outlook Ease AI Disruption Fears
Accenture shares surged after the company exceeded quarterly earnings and revenue expectations, reported strong bookings and issued an outlook that eased concerns about artificial intelligence disruption.
AI demand fuels Micron earnings beat
D.A. Davidson Head of Technology Research Gil Luria joins Market Domination Overtime to discuss Micron (MU) Q4 earnings report.
00:00 Speaker A
And Micron earnings just crossing the wire reporting fourth quarter adjusted revenue of $54.23 uh billion. So Bloom…
The man who told readers to buy Amazon at $1.50 says AI's real breakthrough hasn't happened yet
Porter Stansberry spent months investigating a little-known technology quietly being adopted by Nvidia and Microsoft — one estimate puts the market at $100 trillion. He calls it the Final Frontier of the technology age.
🔍 Market Analysis & Insights
Micron stock has surged 275% this year; MU earnings beat Wall Street estimates as AI demand fuels $60 billion-$63 billion revenue outlook
MU stock today: Micron reported better-than-expected earnings, resulting in a significant stock increase for the company this year. The company is projecting future revenue between $60 billion and $63 billion, exceeding analyst forecasts. Driven by strong dem…
Here’s what happened in crypto today
SEC just proposed to let advisers hold clients’ crypto themselves when no approved custodian exists and to greenlight state trust companies as custodians, finally unclogging a key hurdle that’s been choking off digital-asset offerings. Meanwhile, New York and Wyoming regulators inked a pact to swap exam data, synchronize licensing and enforcement, and fast-track approval for clean firms, because state-based fiefdoms are so last decade. And across the pond, ESMA and national watchdogs have Binanc
Crypto shorts lose $110 million in a 10-minute liquidation burst
The rapid liquidation highlights the inherent volatility in crypto markets, potentially deterring risk-averse investors and amplifying market swings.
The post Crypto shorts lose $110 million in a 10-minute liquidation burst appeared first on Crypto Briefing.
Crypto shorts take the brunt of $102 million liquidation wave
The liquidation wave highlights the risks of aggressive leverage in volatile markets, potentially leading to self-reinforcing price surges.
The post Crypto shorts take the brunt of $102 million liquidation wave appeared first on Crypto Briefing.
Cronus Pharma Announces the Launch of Florfinasone™ Otic for the Treatment of Otitis Externa in Dogs
EAST BRUNSWICK, N.J. — Cronus Pharma LLC, a fully integrated animal health company, today announced the launch of Florfinasone Otic (florfenicol, terbinafine, mometasone furoate), an FDA-approved product indicated for the treatment of otitis externa in dogs a…
Did President Trump Just Privatize the U.S. Dollar?
Three days into his term, Trump signed a sweeping executive order to reboot the dollar — and his plan is finally coming to fruition, with Elon Musk leading the charge. Within weeks, America could have a new currency, and life as we know it may never be the same.
💰 Investment Opportunities
Bitcoin buyers clear the $85K sell wall, opening a path for upside
The removal of Bitcoin's sell wall at $85K could trigger increased volatility and potential price surges, impacting market dynamics significantly.
The post Bitcoin buyers clear the $85K sell wall, opening a path for upside appeared first on Crypto Briefing.
Keltie Knight Opens Up About How Prozac Affected Her Sex Drive
For The LadyGang’s Keltie Knight, the topic of women’s sexual health has stayed under the covers long enough. “We really wanted to use this as an opportunity to have an actual conversation where we can talk about things we’re embarrassed to talk about,” Knigh…
European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀
European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀manilatimes.net
Dow Slips as Treasury Yields Hit Highest Since 2002, Oil Jumps, Even as Micron and Accenture Lift Tech Stocks
The Dow fell in early trading as Treasury yields reached their highest levels in more than two decades and oil prices rose, offsetting gains in technology stocks.
Dad says autism ‘miracle drug’ drastically and immediately improved his son’s severe symptoms
“It changed everything for us,” Matthew Bielski said of his 4-year-old son Lev’s dramatic “life-changing transformation.” “He went from the least affectionate kid to the most affectionate kid almost overnight.”
Missed the AI Boom? This $20 Stock Could Be Bigger
My readers saw gains as high as 502% on my past AI picks. But the next one? It could be even bigger. Warren Buffett owns $40B in this sector. Elon Musk says it's essential for civilization.